Literature DB >> 3530348

What should be the morphologic criteria for the subdivision of follicular lymphomas?

B N Nathwani, G E Metter, T P Miller, J S Burke, R B Mann, M Barcos, C R Kjeldsberg, D O Dixon, C D Winberg, C C Whitcomb.   

Abstract

The members of the Pathology Panel for Lymphoma Clinical Studies undertook a collaborative study with the hope of resolving some of the controversies regarding the criteria and methods for the subclassification of follicular lymphomas (FLs). A group of 105 patients with FL were subclassified by seven hematopathologists according to two methods. In the first method, cases were subclassified according to the Rappaport, Lukes and Collins, and Working Formulation systems. In each of these systems, FLs are subclassified by estimation of the different cell populations, without actual counting of cells. In the second method, precise counts of different cells were made according to the standard and modified Berard methods. With this counting method, diagnoses were independently derived, based on counts provided by the seven pathologists, for large cleaved (LC), small noncleaved (SNC), and large noncleaved (LNC) cells. To ascertain what method and which criteria are most useful in predicting survival, we made clinicopathologic correlations. When the subjective (first method) diagnoses were rendered, and when the consensus diagnoses of the seven pathologists were used, there were no significant differences in survival among patients with the different subtypes. On the other hand, when we used the counting method of Berard (second method) and the cut-off points for the cell counts suggested by him for the subclassification, we were able to divide the patient population into prognostic subgroups. Because the cut-off points proposed by Berard are not derived objectively, we made statistical comparisons of survival curves to determine cut-off points (and thus to establish objective criteria). We found that the patient population could be separated into at least two prognostic groups, for SNC and/or LNC and for SNC + LNC + LC cells. The cut-off points which we derived differed with cell type, however. Until the usefulness of these new cut-off points is established, we recommend that the cut-off points and the counting method of Berard be used for the subclassification of FL. Because the choice of treatment for the different subtypes of FL is totally dependent on the histologic diagnosis, and because of the variability among the diagnoses of pathologists, treatment planning is difficult.

Entities:  

Mesh:

Year:  1986        PMID: 3530348

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Use of morphometry in cytological preparations for diagnosing follicular non-Hodgkin's lymphomas.

Authors:  M W Stevens; K S Crowley; N L Fazzalari; A E Woods
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

Review 2.  Gastrointestinal follicular lymphoma: review of the literature.

Authors:  Shuji Yamamoto; Hiroshi Nakase; Kouhei Yamashita; Minoru Matsuura; Mariko Takada; Chiharu Kawanami; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

Review 3.  Management of idiopathic retroperitoneal fibrosis from the urologist's perspective.

Authors:  Surcel Cristian; Mirvald Cristian; Pavelescu Cristian; Gingu Constantin; Carmen Savu; Emre Huri; Ioanel Sinescu
Journal:  Ther Adv Urol       Date:  2015-04

4.  Morphometric analysis of follicular center cell lymphomas.

Authors:  S H Swerdlow; R J Pelstring; R D Collins
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  Application of quantifiable criteria in the Lukes and Collins classification of non-Hodgkin's lymphomas.

Authors:  H Schultz; J Ersbøll
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 6.  Treatment strategies for nodal and gastrointestinal follicular lymphoma: current status and future development.

Authors:  Takuya Watanabe
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

7.  Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.

Authors:  Niklas Gebauer; Britta Mengler; Svenja Kopelke; Alex Frydrychowicz; Alexander Fürschke; Carsten Hackenbroch; Arthur Bauer; Armin Riecke; Nikolaus von Bubnoff; Sebastian Fetscher; Hanno M Witte
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-20       Impact factor: 4.322

8.  Grading of follicular lymphoma using flow cytometry.

Authors:  Walid A Mourad; Faisal Rawas; Mohamed Shoukri; Abdelghani Tbakhi; Mohamed Al Omari; Asma Tulbah; Fouad Al Dayel
Journal:  Ann Saudi Med       Date:  2006 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.